Home

Negative symptoms

Read time: 2 min

Satellite symposium

New insights into the relationships between different symptom domains

What are the relationships between different domains of symptoms of schizophrenia in acute...

Read time: 2 min

Congress highlights

New insights into the pathophysiology and clinical manifestations of schizophrenia

New insights into the genetic risk for schizophrenia, the role of inflammation in schizophrenia...

Read time: 2 min

Congress highlights

“Schizophrenia: One disease or hundreds of diseases?”

Schizophrenia is a heterogeneous disease. The symptoms, course and outcome vary widely among...

Depression, Schizophrenia

Read time: 3 min

Congress highlights

New research shows how brain structure and function change in depression and schizophrenia

There is always more to learn about underlying biology in medicine, and this is especially true in...

Read time: 2 min

Congress highlights

Partial dopamine agonists: wide spectrum of activity and indications

Dopamine partial agonists decrease transmission when there is excess of the neurotransmitter, but...

Read time: 2 min

Congress highlights

Rethinking ‘persistence’ in negative symptoms for better functional recovery

Even short-term persistence of negative symptoms is associated with reduced clinical and real-life...

Read time: 2 min

Satellite symposium

Improving positive and negative symptoms with dopamine D2 partial agonists

Dopamine D2 partial agonists can ameliorate both positive and negative symptoms of schizophrenia...

Read time: 3 min

Congress highlights

Best publications in 2019

In this session, Prof Pierre Llorca, France, presented important publications in the field of...

Read time: 2 min

Congress highlights

Negative symptoms improved by early intervention

New EPA guidelines on the diagnosis and management of negative symptoms should help draw attention...

Medical education resource center

Lundbeck Institute Campus

The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Israel
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in the Israel click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country